Octave

United States
New Lisbon, Wisconsin, United States, 94025

Company profile

Octave company profile

Octave develops and offers a blood-based diagnostic platform focused on measuring disease activity in neurodegenerative conditions. It provides the Octave MSDA Test, a multi-analyte biomarker assay that quantifies levels of multiple proteins to assess activity in multiple sclerosis. The company supports clinicians and patients by transforming biomarker data into individualized reports that inform treatment decisions. It continues to expand research into additional biomarkers and disease progression models in neurodegeneration.

Business identity

Phone number
6504590942
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2014-11-01, Month

Headquarters

Postal code
94025
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
9
Total equity funding
$116.6M
Last funding
Grant / 2025-10-06
Last equity funding
Series C / $35.6M
Investors
14
Lead investors
7
Founders
2
Articles
30

Founders and investors

Founders

Melinda ThomasWilliam Hagstrom

Lead investors

Merck Global Health Innovation FundMichael J. Fox FoundationNorthpond VenturesNovartisSilicon Valley BankThe Blue Venture FundValhalla Charitable Foundation

Investors

Casdin CapitalDeerfieldMichael J. Fox FoundationNovartisS32